SLC5A2 and myocardial infarction: The notion of promptly initiating and sustaining SGLT2 inhibition following acute MI is enticing, given the numerous proposed mechanistic effects that could potentially modify the disease's progression, susceptibility to ventricular remodeling, and development of chronic HF and advanced heart disease [28].